Yes, imiquimod 5% cream is indicated for treating simple external genital warts on the penis.
Imiquimod 5% cream is FDA-approved and guideline-recommended as a first-line patient-applied therapy for external genital warts, including penile warts, in immunocompetent patients aged 12 years and older 1.
Dosing and Application
Apply imiquimod 5% cream:
- Once daily at bedtime, 3 times per week (e.g., Monday, Wednesday, Friday)
- Continue for up to 16 weeks or until complete wart clearance
- Wash the treatment area with mild soap and water 6-10 hours after application
- Avoid sexual contact while cream is on the skin 2, 1
Evidence Supporting Use
The CDC STD Treatment Guidelines consistently list imiquimod 5% cream as a recommended patient-applied regimen for external genital warts 2, 3. The FDA label specifically indicates its use for external genital and perianal warts 1.
For uncircumcised men with penile warts: A dose-escalation study demonstrated that the 3 times/week regimen achieved 62% complete clearance and was better tolerated than daily application, with fewer severe local skin reactions 4. Men should retract the foreskin and clean the area daily during treatment 1.
Overall efficacy in men: Clinical trials show complete clearance rates of 33-37% in men (compared to 0-4% with placebo), though response rates are lower than in women (72%) 5, 6, 7. The intent-to-treat clearance rate across studies was approximately 50% for imiquimod versus 4-11% for vehicle 5, 8.
Expected Side Effects and Management
Local inflammatory reactions are common and expected with imiquimod use:
- Most frequent: erythema (33%), burning (31%), itching (54%), erosion (10%), irritation (17%) 7
- These reactions are typically mild to moderate and indicate immune activation 2, 3
- If severe reactions occur, interrupt dosing temporarily and wash off the cream 1
Critical Caveats
Anatomic limitations: Imiquimod has NOT been evaluated for urethral or intra-vaginal warts 1. Use only on external penile skin.
Uncircumcised males: The 3 times/week regimen is optimal—more frequent application (daily or multiple times daily) does NOT improve clearance and significantly increases adverse reactions 4, 6.
Treatment monitoring: Change therapy if no substantial improvement after 3 provider-administered treatments OR if warts haven't cleared after 6 treatments (16 weeks for imiquimod) 2.
Recurrence: Among patients achieving complete clearance, recurrence rates are approximately 19% during follow-up 7, 8.
Alternative Options
If imiquimod fails or is not tolerated, guideline-recommended alternatives include:
- Patient-applied: Podofilox 0.5% solution/gel
- Provider-administered: Cryotherapy, TCA/BCA 80-90%, or surgical removal 2, 3
The choice between patient-applied versus provider-administered therapy depends on patient preference, ability to identify and reach warts, cost, and provider experience 2.